Skip to main content
. 2022 Oct 17;37(10):2061–2068. doi: 10.1038/s41433-022-02286-x

Table 1.

Clinical characteristics of the study subjects.

Diabetic patients (diabetic group, n = 24) Controls (control group, n = 14) P values
Age, years 56.7 ± 1.5 61.4 ± 2.0 0.069
Male/Female 11/15 7/9 0.927
TCho (mmol/L) 4.2 ± 0.2 4.7 ± 0.2 0.149
HDL-C (mmol/L) 1.1 ± 0.0 1.2 ± 0.1 0.221
LDL-C (mmol/L) 2.5 ± 0.1 2.3 ± 0.2 0.286
TG (mmol/L) 1.6 ± 0.2 1.6 ± 0.2 0.856
FBG (mmol/L) 6.9 ± 0.4 5.3 ± 0.2 0.005
ALB (g/L) 39.9 ± 1.2 40.5 ± 0.9 0.721
GLB (g/L) 25.3 ± 1.0 24.7 ± 0.3 0.498
Duration of DM, years 11.2 ± 1.8
BMI (kg/m2) 22.1 ± 0.5 21.8 ± 0.4 0.595
Hypertension, n (%) 14 (53.8%) 5 (31.3%) 0.153

Data were expressed as mean ± standard errors (SE).

TCho Total cholesterol, HDL-C high-density liptein cholesterol, LDL-C low-density liptein cholesterol, TG triglyceride, FBG fasting blood glucose, ALB albumin, GLB globulin, DM diabetes mellitus, BMI body mass index.

Bold indicates significance set at p < 0.05.